| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| bendamustine rituximab mantle cell lymphoma | 1.77 | 0.8 | 9742 | 57 | 43 |
| bendamustine | 0.33 | 0.1 | 761 | 50 | 12 |
| rituximab | 0.69 | 0.6 | 1936 | 15 | 9 |
| mantle | 2 | 0.9 | 5361 | 32 | 6 |
| cell | 1.88 | 0.5 | 3652 | 16 | 4 |
| lymphoma | 1.92 | 0.4 | 5891 | 40 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| bendamustine rituximab mantle cell lymphoma | 0.03 | 0.2 | 1340 | 69 |
| bendamustine and rituximab for lymphoma | 1.57 | 0.5 | 3963 | 65 |
| rituximab for mantle cell lymphoma | 0.95 | 0.8 | 513 | 99 |
| bendamustine rituximab follicular lymphoma | 1.08 | 0.5 | 4682 | 80 |
| rituximab maintenance mantle cell lymphoma | 1.62 | 0.5 | 94 | 63 |
| bendamustine and rituxan for lymphoma | 0.93 | 0.7 | 3313 | 72 |
| ibrutinib rituximab mantle cell lymphoma | 0.29 | 1 | 7621 | 26 |
| bendamustine and rituximab for cll | 0.5 | 1 | 1127 | 46 |
| revlimid rituximab mantle cell lymphoma | 0.09 | 0.9 | 8068 | 55 |
| bendamustine and rituximab macmillan | 0.34 | 0.3 | 4278 | 79 |
| bendamustine and rituximab protocol | 1.01 | 0.5 | 7243 | 68 |
| acalabrutinib rituximab mantle cell lymphoma | 1.1 | 0.3 | 8425 | 73 |
| follicular lymphoma bendamustine and rituxan | 0.02 | 0.7 | 7805 | 72 |
| rituxan for mantle cell lymphoma | 1.19 | 0.3 | 2690 | 27 |
| bendamustine rituximab waldenstrom protocol | 1.21 | 0.8 | 7292 | 49 |
| rituximab and bendamustine treatment | 0.67 | 0.3 | 4592 | 5 |
| rituximab and bendamustine regimen | 1.56 | 0.6 | 3141 | 71 |
| fiche patient rituximab bendamustine | 0.56 | 0.4 | 9795 | 66 |
